Sant. Cancer du sein et reconstruction mammaire immdiate de ... - Le Dauphin Libr
SRFT Stock | ILS 4,193 3.00 0.07% |
About 53% of Sarfati's investor base is interested to short. The analysis of current outlook of investing in Sarfati suggests that many traders are impartial regarding Sarfati's prospects. The current market sentiment, together with Sarfati's historical and current headlines, can help investors time the market. In addition, many technical investors use Sarfati stock news signals to limit their universe of possible portfolio assets.
Sarfati |
Sant. Cancer du sein et reconstruction mammaire immdiate de ... Le Dauphin Libr
Read at news.google.com
Sarfati Fundamental Analysis
We analyze Sarfati's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sarfati using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sarfati based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Sarfati is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Sarfati Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sarfati stock to make a market-neutral strategy. Peer analysis of Sarfati could also be used in its relative valuation, which is a method of valuing Sarfati by comparing valuation metrics with similar companies.
Peers
Sarfati Related Equities
AZRG | Azrieli | 1.26 |
| ||
DSCT | Israel Discount | 1.43 |
| ||
DLEKG | Delek | 1.63 |
| ||
SKBN | Shikun Binui | 1.85 |
|
Complementary Tools for Sarfati Stock analysis
When running Sarfati's price analysis, check to measure Sarfati's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarfati is operating at the current time. Most of Sarfati's value examination focuses on studying past and present price action to predict the probability of Sarfati's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarfati's price. Additionally, you may evaluate how the addition of Sarfati to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |